Détails du rapport Vaer
Âge: N/A
Genre: Female
Région : Outside US
- Patient décédé?
- Non
- Renseignements sur les vaccins
-
Nom: COVID19 (COVID19 (PFIZER-BIONTECH))
Type : Coronavirus 2019 vaccine
Fabricant: PFIZER
Lot: fk0112
- Date de réception du rapport
- 2022-03-04
- Date à laquelle le formulaire est complèté
- Date de vaccination
- 2021-11-01
- Date d’apparition
- 8
- Nombre de jours (date d’apparition – date de vaccination)
- 8
- Description de l’événement indésirable
-
photopsia/ visual flashes; tinnitus aggravated; migraine; retinal migraine; tearfulness; injection site pain; visual disturbance; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from a regulatory authority. the reporter is the patient. regulatory number: gb-mhra-webcovid-202202272113366630-mvbrw. other case identifier(s): gb-mhra-adr 26657297. a female patient received bnt162b2 (comirnaty), administration date nov2021 (lot number: fk0112) as dose 3 (booster), single for covid-19 immunisation. relevant medical history included: "tinnitus" (unspecified if ongoing). the patient's concomitant medications were not reported. vaccination history included: bnt162b2 (dose 2, single, lot number: em4965), administration date: apr2021, for covid-19 immunisation; bnt162b2 (dose 1, single, lot number: unknown), for covid-19 immunisation. the following information was reported: visual impairment (disability, medically significant) with onset 2021, outcome "recovering", described as "visual disturbance"; photopsia (disability, medically significant) with onset 25nov2021, outcome "not recovered", described as "photopsia/ visual flashes"; tinnitus (disability, medically significant) with onset 25nov2021, outcome "not recovered", described as "tinnitus aggravated"; migraine (disability, medically significant) with onset 25nov2021, outcome "not recovered", described as "migraine"; retinal migraine (disability, medically significant) with onset 25nov2021, outcome "not recovered", described as "retinal migraine"; tearfulness (disability, medically significant) with onset 25nov2021, outcome "not recovered", described as "tearfulness"; vaccination site pain (disability, medically significant) with onset 09nov2021, outcome "recovered" (16nov2021), described as "injection site pain". the patient reported that exactly two weeks after booster new visual disturbance (flashing) started and it had continued, it affects all aspects of life. the patient underwent the following laboratory tests and procedures: investigation: unknown results; magnetic resonance imaging: unknown results. the patient had numerous investigations, spent a lot of time and money looking for answers of opthalmic reports, mris etc and truly with the patient never had the booster. the patient had not tested positive for covid-19 since having the vaccine. no follow-up attempts are possible. no further information is expected
- Données de laboratoire
-
test name: investigations; result unstructured data: test result:unknown results; test name: mris; result unstructured data: test result:unknown results
- Liste des symptômes
-
investigation tinnitus migraine photopsia magnetic resonance imaging visual impairment vaccination site pain tearfulness retinal migraine
- Patient décédé?
- Non
- Date de décès
- N/A
- Anomalie congénitale
- false
- Vaccin administré par :
- Other
- Vaccin acheté par :
- Inconnu
- Visite d’un patient à l’urgence?
- Non
- Patient hospitalisé?
- Non
- Séjour à l’hôpital
- Non
- Nombre de jours à l’hôpital
- Non spécifié
- Invalidité permanente?
- Oui
- Allergies:
-
na
- Maladie actuelle
-
na